US FDA questions whether Bayer, J&J drug effective

WASHINGTON, Sept 6 (Reuters) - U.S. drug regulators questioned the effectiveness of an experimental stroke preventer from Bayer and Johnson & Johnson .

. Read More

Free Web Hosting